Novo Nordisk on Tuesday (Dec. 1) became the latest drug manufacturer to take steps to stop certain providers from accessing 340B discounts through contract pharmacies -- though Novo Nordisk’s policy will only affect 340B hospitals, and grantees like Ryan White Clinics and community health centers will still be able access the discounts via contract pharmacies. The policy was quickly slammed by 340B hospitals. Starting Jan. 1, 340B hospitals that have an in-house pharmacy will no longer be able to access...